Redefining the Set of Solutions for Antibiotics Misuse Using Host Response-Based Diagnostics

Kfir Oved, Ph.D., Co-Founder & CTO, R&D, MeMed, Israel

Dr. Kfir Oved outlines some of the greatest obstacles to controlling antibiotic misuse, advice for introducing new products in the clinical setting, describes some of the most exciting new developments emerging for AMR, and summarizes what he is looking forward to at the Advanced Diagnostics for Infectious Disease track at Molecular Diagnostics Europe Summit.